BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25144243)

  • 21. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
    Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
    Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not.
    Xu H; Bourne PA; Spaulding BO; Wang HL
    Hum Pathol; 2007 Apr; 38(4):555-63. PubMed ID: 17316760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.
    Collaud S; Tischler V; Atanassoff A; Wiedl T; Komminoth P; Oehlschlegel C; Weder W; Soltermann A
    BMC Cancer; 2015 Feb; 15():74. PubMed ID: 25884169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Contrasting Role of p16Ink4A Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations.
    Fusco N; Guerini-Rocco E; Del Gobbo A; Franco R; Zito-Marino F; Vaira V; Bulfamante G; Ercoli G; Nosotti M; Palleschi A; Bosari S; Ferrero S
    PLoS One; 2015; 10(12):e0144923. PubMed ID: 26674347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma.
    Hao S; Smith TW; Chu PG; Liu Q; Ok CY; Woda BA; Lu D; Lin P; Wang SA; Dresser K; Rock KL; Jiang Z
    Arch Pathol Lab Med; 2011 Aug; 135(8):1032-6. PubMed ID: 21809995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.
    Fabbri A; Cossa M; Sonzogni A; Papotti M; Righi L; Gatti G; Maisonneuve P; Valeri B; Pastorino U; Pelosi G
    Virchows Arch; 2017 Feb; 470(2):153-164. PubMed ID: 28054150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung.
    Garg R; Bal A; DAS A; Singh N; Singh H
    Turk Patoloji Derg; 2019; 35(1):15-21. PubMed ID: 30070306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder.
    Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z
    Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
    Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
    Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms.
    Barbareschi M; Girlando S; Mauri FA; Arrigoni G; Laurino L; Dalla Palma P; Doglioni C
    J Pathol; 1992 Apr; 166(4):343-50. PubMed ID: 1355531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors.
    Kasajima A; Ishikawa Y; Iwata A; Steiger K; Oka N; Ishida H; Sakurada A; Suzuki H; Kameya T; Konukiewitz B; Klöppel G; Okada Y; Sasano H; Weichert W
    Endocr Relat Cancer; 2018 Mar; 25(3):339-350. PubMed ID: 29326364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.
    Del Gobbo A; Vaira V; Ferrari L; Patriarca C; Di Cristofori A; Ricca D; Caroli M; Rampini P; Bosari S; Ferrero S
    Biomed Res Int; 2015; 2015():413897. PubMed ID: 25695077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD200 Expression in Neuroendocrine Neoplasms.
    Love JE; Thompson K; Kilgore MR; Westerhoff M; Murphy CE; Papanicolau-Sengos A; McCormick KA; Shankaran V; Vandeven N; Miller F; Blom A; Nghiem PT; Kussick SJ
    Am J Clin Pathol; 2017 Sep; 148(3):236-242. PubMed ID: 28821198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of TTF-1 and neuroendocrine markers in the human fetal lung and pulmonary neuroendocrine tumors.
    Miskovic J; Brekalo Z; Vukojevic K; Miskovic HR; Kraljevic D; Todorovic J; Soljic V
    Acta Histochem; 2015; 117(4-5):451-9. PubMed ID: 25722034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular alterations of neuroendocrine tumours of the lung.
    Rossi G; Bertero L; Marchiò C; Papotti M
    Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location.
    Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES
    Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.